In 2023, the mortality rate for malignant neoplasms of the colon, rectum, and anus in the US was 17.4 male deaths per hundred thousand men. The forecasted data from 2024 to 2028 indicate a stabilization and slight decrease in this rate, with a projected value of 17.2 by 2028. The lack of significant fluctuation over these years suggests a stable trend, with an annual average decrease of approximately 0.29%. Year-on-year variations from 2024 to 2028 display marginal decreases of 0.58% in 2026 and 2027, highlighting a steady downward trend.
Future trends to watch for include:
- Advancements in early detection and screening technologies.
- Shifts in healthcare policies affecting access to treatments.
- Public awareness and lifestyle changes that could influence incidence rates.
